Two types of amyloidosis presenting in a single patient: a case series
Open Access
- 5 March 2019
- journal article
- research article
- Published by Springer Nature in Blood Cancer Journal
- Vol. 9 (3) , 1-7
Abstract
The amyloidoses are a group of disorders with overlapping clinical presentations, characterized by aggregation and tissue deposition of misfolded proteins. The nature and source of the amyloidogenic protein determines therapy, therefore correct subtyping is critical to patient management. We report the clinicopathologic features of nine patients diagnosed with two amyloid types confirmed by liquid chromatography-coupled tandem mass spectrometry. The most common types were transthyrethin (n = 9) and immunoglobulin-derived (n = 7). Two patients did not have immunoglobulin-derived amyloidosis despite the presence of a monoclonal gammopathy. Eight patients were diagnosed with two types concurrently, and one patient had an 11-year interval between diagnoses. Histopathological distribution of amyloid was variable with vascular, interstitial, and periosteal deposits seen. Identification of a second type was incidental in seven patients, but led to genetic counselling in one patient and therapy directed at both amyloid subtypes in another. With longer survival of myeloma and AL amyloidosis patients and increasing prevalence of patients with wild-type transthyretin amyloidosis due to an aging population, the phenomenon of two amyloid types in a single patient will be encountered more frequently. In light of revolutionary new therapies for transthyretin amyloidosis (patisiran, tafamidis, and inotersen), recognition of dual amyloid types is highly clinically relevant.Keywords
This publication has 22 references indexed in Scilit:
- 99m Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac AmyloidosesCirculation: Cardiovascular Imaging, 2013
- THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosisCurrent Medical Research and Opinion, 2012
- Amyloidosis: Pathogenesis and New Therapeutic OptionsJournal of Clinical Oncology, 2011
- Classification of amyloidosis by laser microdissection and mass spectrometry–based proteomic analysis in clinical biopsy specimensBlood, 2009
- The occurrence of two types of amyloid in the same patientBritish Journal of Dermatology, 2008
- Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2‐macroglobulinandtau: A population‐based autopsy studyAnnals of Medicine, 2008
- Natural History and Outcome in Systemic AA AmyloidosisNew England Journal of Medicine, 2007
- Immunohistochemical Classification of Amyloid in Surgical Pathology RevisitedAmerican Journal of Surgical Pathology, 2006
- Prevalence of Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2006
- Molecular Mechanisms of AmyloidosisNew England Journal of Medicine, 2003